Lou and his brother Pete Koller co-founded Sick of It All in Queens, New York, back in 1986. The band also features drummer ...

Daiichi Sankyo Company ($DSKYF) announced an update on their ongoing clinical study. Study Overview: Substudy 06D, formally titled “A Phase 1/2 ...

It has been a rough year for Sick Of It All frontman Lou Koller in his battle against cancer, and he returned to social media ...

In her final thoughts regarding gastroesophageal cancer, Laura Bobolts, PharmD, BCOP, overviews patient support services and programs. Laura Bobolts, PharmD, BCOP: It’s an exciting time in the ...

Although treatment of advanced gastroesophageal cancer is increasingly dependent on biomarkers, only about 40% of patients are tested. For patients to fully benefit from the latest targeted therapies, ...

Results of two early-phase trials offered a glimpse of promising new agents in the pipeline for advanced gastroesophageal cancer. In a phase II study, incorporating an investigational PD-1 inhibitor ...

Monitoring levels of DNA shed by tumors and circulating in the bloodstream could help doctors accurately assess how gastroesophageal cancers are responding to treatment, and potentially predict future ...

At the final analysis, the coprimary endpoint of overall survival was not met. Topline data were announced from a phase 3 trial evaluating pembrolizumab (Keytruda ®) plus lenvatinib (Lenvima ®) in ...

Laura Bobolts, PharmD, BCOP, discusses key cost drivers impacting treatments for upper GI and esophageal cancers. Laura Bobolts, PharmD, BCOP: There are 3 main cost drivers I typically think about ...

Perfect Life' Heo Yoon-jung confesses her fight against esophageal cancer.In TV CHOSUN 'Perfect Life', which airs at 8 p.m.